Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC And FDA: “Brief Summary” Improvements Are Priority For McClellan

Executive Summary

FDA will address physicians' "legitimate" concern that direct-to-consumer ads do not provide balanced risk-benefit information, Commissioner McClellan told the National Association of Health Underwriters legislative conference March 25 in Washington, D.C

You may also be interested in...



Pfizer DTC Comments Prescribe Limited Risk Info, Reliance On Physicians

Risk information in direct-to-consumer ads should be designed to prompt more patient-physician dialogue, Pfizer suggested in comments to FDA

Pfizer DTC Comments Prescribe Limited Risk Info, Reliance On Physicians

Risk information in direct-to-consumer ads should be designed to prompt more patient-physician dialogue, Pfizer suggested in comments to FDA

DTC Future: Firms Could Pool Dollars For Educational Spots; “Got Drugs?”

Pharmaceutical companies should devote more of their advertising budgets to collective disease education efforts, Rx Insight CEO Bob Ehrlich said

Related Content

UsernamePublicRestriction

Register

PS041515

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel